BR112023024988A2 - Peptídeos e métodos de uso - Google Patents
Peptídeos e métodos de usoInfo
- Publication number
- BR112023024988A2 BR112023024988A2 BR112023024988A BR112023024988A BR112023024988A2 BR 112023024988 A2 BR112023024988 A2 BR 112023024988A2 BR 112023024988 A BR112023024988 A BR 112023024988A BR 112023024988 A BR112023024988 A BR 112023024988A BR 112023024988 A2 BR112023024988 A2 BR 112023024988A2
- Authority
- BR
- Brazil
- Prior art keywords
- peptides
- methods
- peptide
- synthetic
- neutrophils
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 230000004154 complement system Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 210000000440 neutrophil Anatomy 0.000 abstract 1
- 230000006320 pegylation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/12011—Astroviridae
- C12N2770/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
peptídeos e métodos de uso. a presente invenção fornece peptídeos que são modificações sintéticas do peptídeo polar assortant (pa), incluindo peguilação c-terminal. a invenção proporciona ainda métodos de utilização de pelo menos um peptídeo sintético para regular o sistema complemento e interagir com neutrófilos para alterar a sua ligação e atividade.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163195401P | 2021-06-01 | 2021-06-01 | |
| US202163279423P | 2021-11-15 | 2021-11-15 | |
| PCT/US2022/031559 WO2022256304A1 (en) | 2021-06-01 | 2022-05-31 | Peptides and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023024988A2 true BR112023024988A2 (pt) | 2024-02-20 |
Family
ID=84323526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023024988A BR112023024988A2 (pt) | 2021-06-01 | 2022-05-31 | Peptídeos e métodos de uso |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4346866A1 (pt) |
| KR (1) | KR20240016323A (pt) |
| AU (1) | AU2022286333A1 (pt) |
| BR (1) | BR112023024988A2 (pt) |
| CA (1) | CA3215620A1 (pt) |
| IL (1) | IL308683A (pt) |
| WO (1) | WO2022256304A1 (pt) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10005818B2 (en) * | 2010-07-21 | 2018-06-26 | Realta Holdings, Llc | Derivative peptide compounds and methods of use |
| US9567367B2 (en) * | 2012-01-16 | 2017-02-14 | Atox Bio Ltd. | Synthetic peptides for treatment of bacterial infections |
| LT3286181T (lt) * | 2015-04-22 | 2021-04-26 | Rigel Pharmaceuticals, Inc. | Pirazolo junginiai ir junginių gamybos bei naudojimo būdas |
-
2022
- 2022-05-31 CA CA3215620A patent/CA3215620A1/en active Pending
- 2022-05-31 BR BR112023024988A patent/BR112023024988A2/pt unknown
- 2022-05-31 KR KR1020237044779A patent/KR20240016323A/ko unknown
- 2022-05-31 WO PCT/US2022/031559 patent/WO2022256304A1/en active Application Filing
- 2022-05-31 EP EP22816710.2A patent/EP4346866A1/en active Pending
- 2022-05-31 IL IL308683A patent/IL308683A/en unknown
- 2022-05-31 AU AU2022286333A patent/AU2022286333A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022256304A1 (en) | 2022-12-08 |
| EP4346866A1 (en) | 2024-04-10 |
| CA3215620A1 (en) | 2022-12-08 |
| KR20240016323A (ko) | 2024-02-06 |
| AU2022286333A9 (en) | 2023-11-16 |
| AU2022286333A1 (en) | 2023-11-02 |
| IL308683A (en) | 2024-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112021026376A2 (pt) | Proteínas de fusão flt3l-fc e métodos de uso | |
| CO2019003809A2 (es) | Anticuerpos contra proteína alfa reguladora de señal y métodos de uso | |
| CO2021003724A2 (es) | Proteínas de fijación a sirpα y métodos de uso de estas | |
| BR112018068703A2 (pt) | inibidores substituídos de menin-mll e métodos de uso | |
| BR112022017930A2 (pt) | Anticorpos anticoronavírus e métodos de uso | |
| UY37928A (es) | Anticuerpos anti-cd38 y métodos de uso | |
| AR123115A1 (es) | Composiciones y métodos para la degradación selectiva de proteínas | |
| AR115418A1 (es) | ANTICUERPOS ANTI-SIRPA (PROTEÍNA REGULADORA DE SEÑALES a) Y MÉTODOS DE USO DE LOS MISMOS | |
| PE20191551A1 (es) | Polipeptidos de union al receptor de transferrina disenados | |
| EA201592006A1 (ru) | Новые биспецифические связывающие молекулы с противоопухолевой активностью | |
| CO2018013104A2 (es) | Polipéptidos de fusión cd40l-fc y sus métodos de uso | |
| PE20140673A1 (es) | Nuevos moduladores y metodos para su uso | |
| CL2021003580A1 (es) | Compuestos que comprenden un ligando de proteína de activación de fibroblastos y su uso | |
| BR112016011025A2 (pt) | polipeptídeos anticorpo e seus usos | |
| BR112019011860A2 (pt) | proteína de fusão insulina-fc, sequência de ácido nucleico recombinante que codifica a mesma, vetor, célula eucariótica modificada, kit e método para tratar ou prevenir o diabetes autoimune | |
| MX2022000367A (es) | Heterodimeros, metodos y uso de los mismos. | |
| NZ756224A (en) | Polypeptide variants and uses thereof | |
| EA202091054A1 (ru) | Слитые молекулы на основе антитела против pd-l1 и ил-7 | |
| CL2017000200A1 (es) | Célula huésped mejorada para producir proteinas | |
| BR112021024938A2 (pt) | Anticorpos de receptor 1 de peptídeo natriurético e métodos de uso | |
| BR112022009602A2 (pt) | Anticorpos anti-cd79 ch38c-cd79 chctric, células car-t, e usos dos mesmos | |
| AR115695A1 (es) | Moléculas proteicas multifuncionales que comprenden decorina y uso de estas | |
| BR112019023898A2 (pt) | método para tratamento de câncer gástrico, uso de um anticorpo e composição | |
| MX2017010359A (es) | Cadena alfa del receptor de inmunoglobulina e (ige) de alta afinidad de fusion de fragmento cristalizable (fc). | |
| CO2019012204A2 (es) | Proteínas de unión al antígeno anti-jagged1 |